Zobrazeno 1 - 10 of 800 pro vyhledávání: '"S. Mannisto"'
1
BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS OF A NORDIC PHASE 2 STUDY
Autor: Marianne Brodtkorb, M‐L Karjalainen‐Lindsberg, Sirpa Leppä, Annika Pasanen, K Drott, S. Mannisto, Thomas Stauffer Larsen, Sirkku Jyrkkiö, Harald Holte, Peter Nørgaard, Peter D. Brown, Kristiina Karihtala, Judit Jørgensen, Øystein Fluge, Klaus Beiske, B Wold, Unn‐M Fagerli, Lars Munksgaard
Publikováno v: Leppä, S, Jørgensen, J, Karjalainen-Lindsberg, M-L, Beiske, K, Nørgaard, P, Drott, K, Pasanen, A, Karihtala, K, Mannisto, S, Wold, B, Brodtkorb, M, Fagerli, U-M, Larsen, T S, Munksgaard, L, Fluge, Ø, Jyrkkiö, S, Brown, P D N & Holte, H 2021, ' Biomarker-driven treatment strategy in high risk diffuse large b-cell lymphoma: results of a nordic phase 2 study ', Hematological Oncology, vol. 39, no. Suppl. 2, 027, pp. 57 . https://doi.org/10.1002/hon.27_2879
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0851527fbc61039bee0d0e3a755bd5af
https://doi.org/10.1002/hon.27_2879
Zobrazit plný text záznamu
2
Final analysis of a nordic lymphoma group phase ib/iia trial of pixantrone, etoposide, bendamustine and, in cd20-positive tumors, rituximab in relapsed aggressive b- or t-cell lymphomas
Autor: Peter Meyer, Helle Toldbod, Pieternella J. Lugtenburg, S. Mannisto, Judit Jørgensen, Sirpa Leppä, Harald Holte, Thomas Relander, Giorgio Minotti, Suvi-Katri Leivonen, Knut Liestøl, Francesco d'Amore, Grete F. Lauritzsen, Thomas Stauffer Larsen, Peter de Nully Brown, Unn-Merete Fagerli, P Menna
Publikováno v: d'Amore, F, Leppä, S, Relander, T, Larsen, T S, Brown, P, Jørgensen, J, Mannisto, S, Lugtenburg, P, Leivonen, S-K, Holte, H, Fagerli, U M, Lauritzsen, G F, Meyer, P, Minotti, G, Menna, P, Liestøl, K & Toldbod, H 2021, ' Final analysis of a nordic lymphoma group phase ib/iia trial of pixantrone, etoposide, bendamustine and, in cd20-positive tumors, rituximab in relapsed aggressive b-or t-cell lymphomas ', Hematological Oncology, vol. 39, no. Suppl. 2 . https://doi.org/10.1002/hon.151_2880
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5b31b56c942d5ffecf5d8cd51edbad
https://portal.findresearcher.sdu.dk/da/publications/22bd096c-1682-4ad3-96f7-9ceafa905fb1
Zobrazit plný text záznamu
3
Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma
Autor: Petri T. Kovanen, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppä, S. Mannisto, Francesco d'Amore, Michael Roost Clausen, Marjukka Pollari, Pirkko Kellokumpu-Lehtinen, Pauli Vähämurto, Sirkku Jyrkkiö
Publikováno v: Mannisto, S, Vähämurto, P, Pollari, M, Clausen, M R, Jyrkkiö, S, Kellokumpu-Lehtinen, P L, Kovanen, P, Karjalainen-Lindsberg, M L, d'Amore, F & Leppä, S 2019, ' Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma ', European Journal of Cancer, vol. 115, pp. 27-36 . https://doi.org/10.1016/j.ejca.2019.04.004
Background Testicular lymphoma is a rare malignancy affecting mainly elderly men, the majority representing diffuse large B-cell lymphoma (DLBCL). Its relapse rate is higher than that of nodal DLBCL, often affecting the central nervous system (CNS) w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529f8b5adf293cf7fce2f0632807c165
https://pure.au.dk/portal/da/publications/intravenous-but-not-intrathecal-central-nervous-systemdirected-chemotherapy-improves-survival-in-patients-with-testicular-diffuse-large-bcell-lymphoma(36f0e180-969e-4931-8047-60fcdcaef1fb).html
Zobrazit plný text záznamu
4
YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA INCLUDING BCL-2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE-DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS
Autor: Marja-Liisa Karjalainen-Lindsberg, Mats Jerkeman, E. Ralfkiaer, S. Mannisto, Signe Spetalen, Øystein Fluge, Leo Meriranta, Unn-Merete Fagerli, Thomas Stauffer Larsen, Sirpa Leppä, Lars Munksgaard, Harald Holte, Magnus Björkholm, Ingunn Østlie, Kaija Vasala, Anne Tierens, Peter de Nully Brown, Judit Jørgensen, Martin Maisenhölder, Sirkku Jyrkkiö, Peter Meyer
Publikováno v: Leppä, S, Jørgensen, J, Tierens, A, Meriranta, L, Østlie, I, Brown, P D N, Fagerli, U-M, Larsen, T S, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Bjorkholm, M, Fluge, O, Jyrkkio, S, Ralfkiær, E M, Spetalen, S, Karjalainen-Lindsberg, M-L & Holte, H 2019, ' YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA INCLUDING BCL-2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE-DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS ', Hematological Oncology, vol. 37, no. S2, pp. 132-132 . https://doi.org/10.1002/hon.92_2629
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b8d1dd4fbd947059855e55941dd638
https://doi.org/10.1002/hon.92_2629
Zobrazit plný text záznamu
5
DOSE-DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH-RISK DLBCL: A COMPARISON OF NORDIC CRY-04 AND CHIC STUDIES
Autor: Peter Meyer, Unn-Merete Fagerli, L. M. Pedersen, Judit Joergensen, Kaija Vasala, Sirkku Jyrkkiö, Øystein Fluge, Lars Munksgaard, Mats Jerkeman, Mikael Eriksson, Peter de Nully Brown, Thomas Stauffer Larsen, Martin Maisenhölder, Sirpa Leppä, Harald Holte, R. Janes, S. Mannisto, Magnus Björkholm
Publikováno v: Leppa, S, Joergensen, J, Brown, P D N, Fagerli, U, Larsen, T S, Janes, R, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Pedersen, L M, Eriksson, M & Holte, H 2017, ' Dose-dense chemoimmunotherapy and CNS prophylaxis in patients with high-risk DLBCL : a comparison of Nordic CRY-04 and CHIC studies ', Hematological Oncology
, vol. 35, no. S2, pp. 199–200 . https://doi.org/10.1002/hon.2438_62
Leppa, S, Joergensen, J, Brown, P, Fagerli, U, Larsen, T S, Janes, R, Mannisto, S, Munksgaard, L, Maisenhölder, M, Vasala, K, Meyer, P, Jerkeman, M, Björkholm, M, Fluge, Ø, Jyrkkiö, S, Pedersen, L M, Eriksson, M & Holte, H 2017, ' Dose-dense chemoimmunotherapy and CNS prophylaxis in patients with high-risk DLBCL: a comparison of Nordic CRY-04 and CHIC studies ', ICML-14, Lugano, Schweiz, 14/06/2017-17/06/2017 .
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34fd92f027058ba8ecb4a2895e1191b
https://doi.org/10.1002/hon.2438_62
Zobrazit plný text záznamu
9
Akademický článek
Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease.
Autor: Lodge, Mareca1 (AUTHOR), Dykes, Rachel1 (AUTHOR), Kennedy, Arion1 (AUTHOR) akmidget@ncsu.edu
Publikováno v: Biomolecules (2218-273X). Jul2024, Vol. 14 Issue 7, p845. 22p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje